Spots Global Cancer Trial Database for gemcitabine, erlotinib
Every month we try and update this database with for gemcitabine, erlotinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas | NCT01600807 | Pancreatic Canc... | Gemcitabine, Er... Gemcitabine, Er... | 18 Years - | Dana-Farber Cancer Institute |